Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Amgen And Allergan To Discuss Data Supporting Biologics License Application For ABP 215, A Biosimilar Candidate To Avastin® (bevacizumab)
THOUSAND OAKS, Calif.
U.S. FDA Confirms Amicus Therapeutics May Submit New Drug Application for Migalastat for Fabry Disease
CRANBURY, N.
Big Pharma-backed E-Scape Bio hits $63M in extended series A
California neurodegenerative disease upstart E-Scape Bio has closed an extension of its series A round, boosting its cash to $63 million.
Lilly fends off Cialis generics with new patent settlement
Under a new patent settlement with multiple generics makers, Eli Lilly’s storied erectile dysfunction med Cialis will keep exclusive protections a little while longer.
AstraZeneca slumps on report CEO is heading to Teva
LONDON (Reuters) - Shares in AstraZeneca fell more than 5 percent on Thursday after the company declined to deny a media report that Chief Executive Pascal Soriot was about to defect to Israel...
Commercial considerations result in hundreds of drug withdrawals in Brazil
As a result of lack of commercial interest, pharmaceutical companies operating in Brazil have withdrawn from the market old and cheap medications, some of them essential and without substitutes.
Could STRAWBERRIES keep you sharp? Compound in the fruit prevents age-related mental decline
Strawberries could help prevent age-related mental decline, new research suggests.
New drug restores memories in brain-damaged mice
For the first time, scientists have reversed memory and learning deficits in mice following traumatic brain injuries.
Daiichi Sankyo links with German academia for cancer research
Japanese pharma major Daiichi Sankyo (TYO.
Years after accelerated approval debacle, FDA panel backs Pfizer's Mylotarg
Seven years after the FDA pushed Pfizer's Mylotarg off the market for flunking a confirmatory trial, it's in line for a return.
Arena Pharmaceuticals Reports Positive Topline Phase 2 Results for Ralinepag in Patients with Pulmonary Arterial Hypertension
SAN DIEGO, July 10, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc.
Тeva intros 2 new strengths of ADHD generic
NORTH WALES, Pa.
501
502
503
504
505
506
507
508
509
